BSX
Boston Scientific Corp
@axmedwulf
• 9 months agoIs The Business Growing?
Is The Business Growing?Yes
In Q4 2024, Boston Scientific posted net sales of $4.56 billion, up 22.4% year‑over‑year, with adjusted EPS of $0.70 .
For the full year 2024, net sales reached $16.75 billion, up ~17.6%, with adjusted EPS of $2.51, up from $2.05 in 2023 .
In Q2 2025, net sales hit $5.06 billion (22.8% growth on a reported basis), with cardiovascular revenue growing ~25.5% and MedSurg ~14.7% operationally. Adjusted EPS came in at $0.75